Drugs / Cefazolin
Cefazolin
also known as
Ancef · Cefamezin · cefazolin sodium · Cefacidil · Cefazolin (Ancef) · Cefazolin: Brand Names Ancef · CEZ · CZO · +1 more
Regulatory milestones approvals, filings & regulatory actions · 10 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (2) | US (FDA) | CEFAZOLIN SODIUM | — | 2024-12-18 – 2026-02-13 | fda.gov ↗ |
| Label expansions (4) | US (FDA) | CEFAZOLIN AND DEXTROSE | — | 2012-01-13 – 2024-08-26 | fda.gov ↗ |
| Label expansions (3) | US (FDA) | CEFAZOLIN IN DEXTROSE | — | 2021-02-01 – 2024-05-31 | fda.gov ↗ |
| Approved | US (FDA) | ANCEF | — | 1973-10-04 | fda.gov ↗ |
Trials 77 · started per year
today
US approved 1973
2
2
1
2
2
1
3
4
1
6
2
5
2
2
9
6
2
4
4
5
6
5
197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT06710977 | Jan 2022 → Sep 2024 | cataract | Tan Tock Seng Hospital | Completed | No outcome recorded |
| Phase 0 | NCT03853096 | Apr 2019 → Apr 2020 | — | University of British Columbia | Unknown | No outcome recorded |
| Phase 0 | NCT03801252 | Dec 2018 → Jun 2021 | obesity disorder | University of Oklahoma | Completed | No outcome recorded |
| Phase 17 trials | ||||||
| Phase 1 | NCT05205486 | Apr 2022 → Jul 2023 | infectious disease | B. Braun Medical SA | Completed | No outcome recorded |
| Phase 1 | NCT05309304 | Feb → Aug 2022 | — | Baxter Healthcare Corporation | Completed | No outcome recorded |
| Phase 1 | NCT03672149 | Jul 2019 → Dec 2022 | — | Drexel University | Unknown | No outcome recorded |
| Phase 1 | NCT05367479 | Jul 2018 → Jan 2020 | hypertensive disorder, morbid obesity | Medical College of Wisconsin | Completed | No outcome recorded |
| Phase 1 | NCT01904500 | Aug 2013 → Apr 2014 | obesity disorder, pregnancy disorder | University of Pittsburgh | Completed | No outcome recorded |
| Phase 1 | NCT00850122 | Jul 2013 → Jul 2018 | infectious disease with sepsis | Phillip Brian Smith | Completed | No outcome recorded |
| Phase 1 | NCT01121354 | Dec 2009 → Feb 2010 | infectious disease | B. Braun Medical SA | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT06640491 | May 2025 → Dec 2030 expected | — | The Methodist Hospital Research Institute | Recruiting | No outcome recorded |
| Phase 27 trials | ||||||
| Phase 2 | NCT06406114 | May 2025 → Jul 2028 expected | anaphylaxis, drug allergy, drug pseudoallergy | Massachusetts General Hospital | Recruiting | No outcome recorded |
| Phase 2 | NCT06488781 | Apr 2025 → Dec 2028 expected | pregnancy disorder | University of Oklahoma | Recruiting | No outcome recorded |
| Phase 2 | NCT06327113 | May 2024 → May 2027 expected | chronic ulcer of skin | University of California, Los Angeles | Recruiting | No outcome recorded |
| Phase 2 | NCT06355115 | Sep 2023 → Sep 2024 | — | University of Brawijaya | Unknown | No outcome recorded |
| Phase 2 | NCT03732365 | Feb 2019 → Jan 2020 | chronic ulcer of skin | Sonescence, Inc. | Unknown | No outcome recorded |
| Phase 2 | NCT03578965 | Jul 2018 → Nov 2021 | low grade vulvar intraepithelial neoplasia, vulvar benign neoplasm | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 2 | NCT00438269 | Feb 2003 → Mar 2005 | nosocomial infection, pneumonia | Canadian Critical Care Trials Group | Completed | No outcome recorded |
| Phase 313 trials · 1 met primary · 1 missed | ||||||
| Phase 3 | NCT06576154 | Aug 2024 → Aug 2025 overdue | skin infection | University of Aleppo | Recruiting | No outcome recorded |
| Phase 3 | NCT04731025 | Jan 2021 → Sep 2026 overdue | breast disorder, poisoning, prosthesis-related infectious disease | Mikkel Herly | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06402591 | Jan 2019 → Dec 2023 | periprosthetic joint infection | Radboud University Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT03046511 | Mar 2017 → Dec 2023 | infectious peritonitis | Carmel Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT02838940 | Aug 2016 → Aug 2019 | — | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 3 | NCT02365493 | Aug 2015 → Oct 2018 | methicillin-resistant staphylococcus aureus infectious disease | Menzies School of Health Research | Terminated | Missed primary |
| Phase 3 | NCT03862170 | Feb 2015 → Feb 2020 | prostate cancer | CR-CSSS Champlain-Charles-Le Moyne | Terminated | No outcome recorded |
| Phase 3 | NCT01792804 | Dec 2013 → Mar 2020 | staphylococcus aureus infection | Heinrich-Heine University, Duesseldorf | Completed | Met primary |
| Phase 3 | NCT00811603 | Aug 2008 → Jun 2009 | infectious disease | MemorialCare | Completed | No outcome recorded |
| Phase 3 | NCT01867138 | Mar 2007 → Aug 2010 | neonatal sepsis | Hospital Italiano de Buenos Aires | Completed | No outcome recorded |
| Phase 3 | NCT00108433 | Sep 2005 → Sep 2006 | gram-positive bacterial infections | Pfizer | Terminated | No outcome recorded |
| Phase 3 | NCT00467948 | Jun 2004 → Mar 2006 | larynx cancer | Tehran University of Medical Sciences | Completed | No outcome recorded |
| Phase 3 | NCT00323219 | Jan 2004 → Dec 2012 | cellulitis | University of British Columbia | Completed | No outcome recorded |
| Phase 425 trials | ||||||
| Phase 4 | NCT07655596 | Jul → Sep 2026 overdue | — | Helwan University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07658378 | Jul → Sep 2026 overdue | — | Helwan University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06567808 | Mar 2026 → Apr 2028 expected | skin infection | Hamilton Health Sciences Corporation | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07376889 | Feb 2026 → Jan 2029 expected | staphylococcus aureus infection | Intermountain Health Care, Inc. | Recruiting | No outcome recorded |
| Phase 4 | NCT07549542 | Oct 2025 → Oct 2026 expected | — | Rutgers, The State University of New Jersey | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT07148960 | Sep 2025 → Jul 2027 expected | staphylococcus aureus infection | West Virginia University | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT06920147 | May 2025 → Mar 2027 expected | — | The University of Texas Health Science Center, Houston | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06607887 | Aug → Nov 2024 overdue | skin infection | Minia University Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT05852158 | Jan 2024 → Jan 2027 expected | — | Abdul El-Rabbany | Recruiting | No outcome recorded |
| Phase 4 | NCT06093269 | Nov 2023 → Dec 2025 overdue | bacterial infectious disease | University Hospital, Tours | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05447559 | Feb 2023 → Dec 2027 expected | — | Monash University | Recruiting | No outcome recorded |
| Phase 4 | NCT05137119 | Feb 2022 → Dec 2028 expected | staphylococcus aureus infection | University of Melbourne | Recruiting | Mixed |
| Phase 4 | NCT03675854 | Jan → Sep 2019 | peritonitis | Chinese University of Hong Kong | Withdrawn | No outcome recorded |
| Phase 4 | NCT04516148 | May 2018 → Oct 2020 | skin infection | Medstar Health Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT03478163 | Mar 2018 → May 2021 | endometritis, obstetric disorder | Cedars-Sinai Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03283878 | Oct 2017 → Nov 2024 | osteoarthritis, knee | Duke University | Completed | No outcome recorded |
| Phase 4 | NCT02593201 | Feb 2016 → Dec 2018 | — | Chinese University of Hong Kong | Completed | No outcome recorded |
| Phase 4 | NCT02446782 | Jan 2015 → Apr 2016 | empyema, pleurisy | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| Phase 4 | NCT02049944 | Aug 2013 → Sep 2014 | morbid obesity, pregnancy disorder, puerperal infection | MemorialCare Health System | Completed | No outcome recorded |
| Phase 4 | NCT01899781 | Aug 2013 → Jan 2015 | disease of the tendon | HaEmek Medical Center, Israel | Completed | No outcome recorded |
| Phase 4 | NCT01458223 | Oct 2011 → Aug 2018 | — | The London Spine Centre | Completed | No outcome recorded |
| Phase 4 | NCT01845363 | Jun → Oct 2011 | obesity disorder | Federal University of Pernambuco | Completed | No outcome recorded |
| Phase 4 | NCT01880112 | Jun 2011 → Jun 2013 | infectious disease | West Virginia University | Withdrawn | No outcome recorded |
| Phase 4 | NCT01755026 | Nov 2010 → Jul 2011 | obesity disorder, skin infection | Michael Stitely | Completed | No outcome recorded |
| Phase 4 | NCT00550290 | Oct 2007 → Apr 2009 | skin infection | Aultman Health Foundation | Completed | No outcome recorded |
| Phase not applicable20 trials · 2 met primary · 3 missed | ||||||
| — | NCT07043855 | May 2026 → Oct 2028 expected | infectious disease | Asan Medical Center | Enrolling by invitation | No outcome recorded |
| — | NCT05304871 | Jan 2024 → Mar 2027 | — | Dartmouth-Hitchcock Medical Center | Withdrawn | No outcome recorded Stop: Business |
| — | NCT07111702 | Oct 2023 → May 2024 | — | Sana'a University | Completed | No outcome recorded |
| — | NCT04763486 | Mar 2021 → Mar 2022 | puerperal infection | Meir Medical Center | Unknown | No outcome recorded |
| — | NCT06030713 | Mar 2019 → Oct 2022 | poisoning | University Medical Center Groningen | Completed | No outcome recorded |
| — | NCT03248063 | Sep 2018 → Feb 2024 | methicillin-susceptible staphylococcus aureus infectious disease | Assistance Publique - Hôpitaux de Paris | Completed | Met primary |
| — | NCT03742908 | Jun 2018 → Oct 2021 | breast neoplasm | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
| — | NCT04818931 | Apr 2018 → Jun 2019 | breast cancer | CHU de Quebec-Universite Laval | Completed | Missed primary |
| — | NCT03595852 | Mar → Sep 2018 | — | University of Rwanda | Completed | No outcome recorded |
| — | NCT02285140 | Apr 2015 → Mar 2025 | — | Hamilton Health Sciences Corporation | Terminated | No outcome recorded Stop: Business |
| — | NCT02404064 | Mar 2015 | appendicitis | HaEmek Medical Center, Israel | Unknown | No outcome recorded |
| — | NCT02368015 | Dec 2014 → Dec 2015 | — | Radboud University Medical Center | Completed | No outcome recorded |
| — | NCT02216227 | Apr 2014 → Feb 2021 | — | VA Office of Research and Development | Completed | Missed primary |
| — | NCT01810354 | Apr 2013 → Jul 2014 | — | Women and Infants Hospital of Rhode Island | Completed | Missed primary |
| — | NCT01785641 | Dec 2012 → Dec 2013 | peritonitis | Chulalongkorn University | Completed | No outcome recorded |
| — | NCT01420367 | Nov 2011 → Nov 2013 | appendicitis | Monash University | Completed | No outcome recorded |
| — | NCT01805856 | Nov 2010 → May 2012 | parathyroid gland disorder, thyroid gland disorder | Ito Hospital | Completed | No outcome recorded |
| — | NCT01114516 | Mar 2010 → Mar 2013 | cervical incompetence | Northwestern University | Completed | Met primary |
| — | NCT00805545 | Nov 2008 → Nov 2009 | infectious disease | University of Florida | Completed | No outcome recorded |
| — | NCT00330278 | Jan 2003 → Jan 2006 | endometritis, skin infection | Medical University of South Carolina | Completed | No outcome recorded |
| Phase not stated1 trial | ||||||
| — | NCT01238276 | — | cellulitis, ulcer of lower limbs | Sonescence, Inc. | No longer available | No outcome recorded |
| Comparator or background therapy99 trials | ||||||
| Phase 0 | NCT05849090 Comparator | Mar 2023 → Dec 2024 | infectious disease | University of Utah | Completed | No outcome recorded |
| Phase 1 | NCT04875728 Comparator | Sep 2020 → Feb 2027 expected | cutaneous melanoma | M.D. Anderson Cancer Center | Active not recruiting | No outcome recorded |
| Phase 1 | NCT03213249 Comparator | Jul 2017 → Sep 2018 | breast disorder | Washington University School of Medicine | Completed | No outcome recorded |
| Phase 1 | NCT01904357 Comparator | Mar → Aug 2013 | infectious disease | B. Braun Medical SA | Completed | No outcome recorded |
| Phase 1/2 | NCT03502356 Comparator | Apr → Jun 2018 | — | Ain Shams University | Unknown | No outcome recorded |
| Phase 1/2 | NCT03466645 Comparator | Apr 2018 → Apr 2019 | — | Isfahan University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1/2 | NCT02493894 Background | Jul 2014 → May 2015 | — | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT07308938 Background | Oct 2026 → Dec 2029 expected | corneal ulcer | Vishal Jhanji | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT05655091 Comparator | Oct 2023 → Dec 2025 overdue | staphylococcus aureus infection | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
| Phase 2 | NCT05162625 Comparator | Dec 2021 → Dec 2022 | acute endophthalmitis | University of Campinas, Brazil | Unknown | No outcome recorded |
| Phase 2 | NCT04775953 Comparator | Apr 2021 → Oct 2023 | staphylococcal infection | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
| Phase 2 | NCT03723551 Comparator | Feb 2019 → Apr 2025 | bacterial infectious disease | Debiopharm International SA | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT01756924 Comparator | Dec 2012 → Jul 2014 | periprosthetic joint infection | Arrevus Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT01029782 Comparator | May 2010 → Oct 2014 | cellulitis | Kelowna General Hospital | Completed | No outcome recorded |
| Phase 2/3 | NCT03226626 Background | Dec 2021 → Jan 2022 | infectious disease with sepsis, thrombotic disease | HK Surgical, Inc. | Unknown | No outcome recorded |
| Phase 2/3 | NCT02503904 Comparator | Oct 2015 → Jun 2019 | venous thromboembolism | Klein, Jeffrey A., M.D. | Unknown | No outcome recorded |
| Phase 2/3 | NCT01400867 Comparator | Dec 2011 → May 2014 | primary bacterial infectious disease | Forest Laboratories | Completed | No outcome recorded |
| Phase 2/3 | NCT01127880 Comparator | Jul 2005 → Dec 2009 | hemopneumothorax | St. Luke's Hospital, Pennsylvania | Completed | No outcome recorded |
| Phase 3 | NCT06336824 Comparator | Jun 2024 → May 2025 overdue | staphylococcus aureus infection | Clinical Research Centre, Malaysia | Recruiting | No outcome recorded |
| Phase 3 | NCT04292054 Comparator | Oct 2020 → Apr 2026 overdue | — | Assistance Publique - Hôpitaux de Paris | Recruiting | No outcome recorded |
| Phase 3 | NCT03176134 Comparator | Jan 2019 → Jul 2023 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT02717871 Comparator | Mar 2016 → Oct 2020 | keratitis | University Hospital, Geneva | Completed | No outcome recorded |
| Phase 3 | NCT02344511 Comparator | Mar 2016 → Oct 2018 | osteomyelitis | Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) | Withdrawn | No outcome recorded |
| Phase 3 | NCT02276482 Comparator | Mar 2015 → Sep 2018 | skin disease caused by bacterial infection, skin infection | Merck & Co., Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02208063 Comparator | Dec 2014 → Apr 2018 | bacterial infectious disease | Cumberland Pharmaceuticals | Terminated | No outcome recorded |
| Phase 3 | NCT02579161 Comparator | Sep 2014 → Mar 2018 | urolithiasis | Northwell Health | Completed | No outcome recorded |
| Phase 3 | NCT01479283 Comparator | Jan 2013 → Mar 2021 | bone neoplasm, infectious disease | McMaster University | Completed | No outcome recorded |
| Phase 3 | NCT01503606 Comparator | Oct 2011 → Dec 2020 | preterm premature rupture of the membranes | Samsung Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT01002911 Background | Dec 2009 → Jan 2012 | cardiac rhythm disease | Population Health Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT00867295 Comparator | Sep 2008 → Dec 2009 | neoplasm | Istanbul University | Completed | No outcome recorded |
| Phase 3 | NCT00636831 Comparator | Jul 2007 → Jan 2012 | — | Nihon University | Completed | No outcome recorded |
| Phase 3 | NCT01401179 Comparator | Apr 2005 → Apr 2010 | preterm premature rupture of the membranes | Samsung Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT07608562 Background | Aug 2026 → Jun 2028 expected | cervical incompetence | Wake Forest University Health Sciences | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07072923 Comparator | Sep 2025 → Jul 2027 expected | osteomyelitis | University of Arizona | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06055712 Comparator | Sep 2023 → Sep 2033 expected | infectious disease | St. Louis University | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT05977868 Comparator | Aug 2023 → Feb 2025 | digestive system infectious disorder | West Virginia University | Terminated | No outcome recorded |
| Phase 4 | NCT05971537 Comparator | Jun 2023 → Oct 2026 expected | infectious peritonitis | Alice Ho Miu Ling Nethersole Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT05199324 Comparator | Jun 2022 → May 2026 overdue | gram-negative bacterial infections | Tan Tock Seng Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT05132829 Background | Dec 2021 → Dec 2024 | cervical incompetence, pregnancy disorder | Thomas Jefferson University | Unknown | Missed primary |
| Phase 4 | NCT04707092 Background | Jun 2021 → Jun 2022 | ear infection, poisoning | Sunnybrook Health Sciences Centre | Unknown | No outcome recorded |
| Phase 4 | NCT04538053 Comparator | Jun 2021 → Dec 2026 expected | infective arthritis, osteomyelitis | Murdoch Childrens Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT04766996 Background | May → Dec 2021 | substance-related disorder | Emory University | Terminated | No outcome recorded |
| Phase 4 | NCT04834310 Background | Apr 2021 → May 2024 | breast disorder, poisoning | University of California, Los Angeles | Withdrawn | No outcome recorded Stop: Business |
| Phase 4 | NCT04141787 Comparator | Jul 2019 → Jul 2023 | abscess, bacterial arthritis, infectious disorder of the nervous system, osteomyelitis +1 | Vancouver Island Health Authority | Unknown | No outcome recorded |
| Phase 4 | NCT04062175 Comparator | Mar → Jun 2019 | infectious disease with sepsis | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT03560232 Comparator | Jul 2018 → Feb 2020 | — | Mercy Health Ohio | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT03190668 Comparator | May 2018 → Jun 2022 | idiopathic scoliosis | University of Florida | Completed | No outcome recorded |
| Phase 4 | NCT03432858 Comparator | May 2018 → Dec 2020 | carpal tunnel syndrome | WellSpan Health | Completed | No outcome recorded |
| Phase 4 | NCT03402945 Comparator | Mar 2018 → Apr 2023 | — | Population Health Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT04303390 Comparator | Feb 2018 → May 2022 | — | Saud Al Babtain Cardiac Center | Completed | No outcome recorded |
| Phase 4 | NCT03231228 Comparator | Nov 2017 → Jul 2019 | — | B. Braun Medical SA | Terminated | No outcome recorded |
| Phase 4 | NCT01886742 Comparator | Sep 2017 → Oct 2018 | obesity disorder | University of Colorado, Denver | Withdrawn | No outcome recorded Stop: Business |
| Phase 4 | NCT03261830 Comparator | Aug 2017 → Mar 2023 | — | Sumit Gupta | Completed | No outcome recorded |
| Phase 4 | NCT03094663 Background | Feb 2017 → May 2018 | arthropathy | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| Phase 4 | NCT02872038 Comparator | Aug 2015 → Nov 2016 | infectious peritonitis | Chulalongkorn University | Completed | Met primary |
| Phase 4 | NCT02433704 Comparator | May 2015 → May 2017 | periprosthetic joint infection | Duke University | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT02307006 Comparator | Jan 2015 → Dec 2016 | — | University of Cincinnati | Unknown | No outcome recorded |
| Phase 4 | NCT02534961 Comparator | Jan 2015 → Dec 2017 | hepatocellular carcinoma | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| Phase 4 | NCT02324166 Comparator | Jan 2015 → Jan 2016 | endophthalmitis | University Health Network, Toronto | Unknown | No outcome recorded |
| Phase 4 | NCT02292082 Background | Nov 2014 → Aug 2016 | osteoarthritis | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| Phase 4 | NCT02225821 Comparator | Nov 2014 → Nov 2016 | — | Academic Medical Center - University of Amsterdam | Completed | No outcome recorded |
| Phase 4 | NCT01980082 Comparator | Jan 2014 → Jun 2017 | — | Rabin Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT02012517 Comparator | Jan 2014 → Dec 2016 | — | Sheba Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT01628666 Background | Dec 2012 → Sep 2017 | cardiac rhythm disease | Population Health Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT01721616 Comparator | Nov 2012 → Nov 2014 | endometritis | University of Missouri, Kansas City | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT01619982 Comparator | Feb 2012 → Dec 2014 | aortic valve disorder, congenital heart disease | Stanford University | Completed | No outcome recorded |
| Phase 4 | NCT01613092 Background | May 2011 → Nov 2013 | cardiac rhythm disease | Population Health Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT01612052 Comparator | May 2011 → Mar 2013 | methicillin-resistant staphylococcus aureus infectious disease | CAMC Health System | Unknown | No outcome recorded |
| Phase 4 | NCT01295606 Comparator | Feb → Dec 2011 | — | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
| Phase 4 | NCT01273818 Comparator | Jan 2011 → Feb 2013 | — | Diskapi Teaching and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03877289 Background | Oct 2008 → Jul 2014 | cystitis | University of Calgary | Completed | No outcome recorded |
| Phase 4 | NCT00634166 Background | Sep 2007 → Dec 2013 | — | Mylan Inc. | Terminated | No outcome recorded |
| — | NCT07478874 Comparator | Jul → Dec 2025 | — | Lahore General Hospital | Completed | No outcome recorded |
| — | NCT07032883 Background | Jun 2025 → Feb 2026 overdue | female breast carcinoma | Cairo University | Not yet recruiting | No outcome recorded |
| — | NCT06510452 Comparator | Oct 2024 → Dec 2025 overdue | — | General Committee of Teaching Hospitals and Institutes, Egypt | Not yet recruiting | No outcome recorded |
| — | NCT06189885 Background | Aug 2024 → Jul 2026 overdue | periprosthetic joint infection | Chang Gung Memorial Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07337135 Background | Oct 2023 → Apr 2024 | morbid obesity | Hospital dos Lusíadas | Completed | No outcome recorded |
| — | NCT05647993 Background | Dec 2022 → Nov 2023 | — | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
| — | NCT03593252 Background | Jan 2022 → Jan 2024 | Hirschsprung disease, inflammatory bowel disease, meconium ileus, necrotizing enterocolitis | McMaster University | Unknown | No outcome recorded |
| — | NCT04998513 Comparator | Jan 2022 | peritonsillar abscess | Nova Scotia Health Authority | Withdrawn | No outcome recorded |
| — | NCT04631185 Background | May 2021 → Dec 2023 | — | The Plastic Surgery Foundation | Completed | No outcome recorded |
| — | NCT04288206 Comparator | Jan 2021 → Oct 2023 | infectious disease | Legacy Health System | Unknown | No outcome recorded |
| — | NCT04146883 Background | Aug 2019 → Aug 2020 | prosthesis-related infectious disease | National Cheng-Kung University Hospital | Unknown | No outcome recorded |
| — | NCT02996656 Comparator | Dec 2016 → Dec 2026 expected | bacterial infectious disease | University of Montreal | Recruiting | No outcome recorded |
| — | NCT02800785 Comparator | May 2016 → Mar 2020 | appendicitis | University of Washington | Completed | No outcome recorded |
| — | NCT02395614 Comparator | Dec 2015 → Dec 2020 | breast cancer | Vanderbilt University Medical Center | Completed | No outcome recorded |
| — | NCT03115177 Comparator | Nov 2015 → Feb 2017 | osteoarthritis | Rush University Medical Center | Completed | No outcome recorded |
| — | NCT02497365 Comparator | Sep 2015 → Jun 2019 | keratitis | McGill University Health Centre/Research Institute of the McGill University Health Centre | Completed | No outcome recorded |
| — | NCT02502877 Background | Jul 2015 → Mar 2016 | — | Hospital da Luz, Portugal | Completed | No outcome recorded |
| — | NCT02809729 Comparator | Jan 2015 → Apr 2017 | female breast carcinoma, skin infection | Fabiola Soares Moreira Campos | Completed | No outcome recorded |
| — | NCT02058979 Comparator | Nov 2014 → Jun 2016 | — | University of Virginia | Completed | No outcome recorded |
| — | NCT02413034 Comparator | Nov 2013 → Dec 2014 | periprosthetic joint infection | Parc de Salut Mar | Completed | No outcome recorded |
| — | NCT01991834 Comparator | Sep 2013 → Mar 2015 | infectious disease | Universidade do Vale do Sapucai | Completed | No outcome recorded |
| — | NCT01823523 Comparator | Jun 2013 → Oct 2015 | craniofacial and skeletal defects | Atlantic Center for Oral and Maxillofacial Surgery | Unknown | No outcome recorded |
| — | NCT02027532 Comparator | Oct 2009 → Jun 2015 | infectious disease | University of Tennessee | Terminated | No outcome recorded |
| — | NCT00818766 Comparator | Mar 2008 → Apr 2011 | — | Brigham and Women's Hospital | Completed | No outcome recorded |
| — | NCT00610987 Comparator | Jan 2008 → Jan 2014 | — | University of Missouri-Columbia | Completed | No outcome recorded |
| — | NCT00787553 Comparator | Jul 2006 → Dec 2008 | — | University of Campinas, Brazil | Unknown | No outcome recorded |
| — | NCT01248078 Comparator | Mar 2004 → Jan 2010 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 177 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cefazolin | “The investigators want to compare whether Methicillin-resistant Staphylococcus Aureaus (MRSA) antibiotic prophylaxis with Cefazolin plus Daptomycin is superior to Cefazolin...” NCT01612052 ↗168“The medical intervention consists of intravenous dexamethasone (10 mg if bodyweight \< 70 kilograms, 20 mg if bodyweight \> 70 kilograms), intravenous cefazolin 2 grams,...” NCT04998513 ↗ “Possible prescribed antibiotics include: trimethoprim and sulfamethoxazole (Septra), Cefalotin, Cephalexin, Cefapirin, Cefdroxil, Cefazolin, Cefradine, Cefacetrile,...” NCT03877289 ↗ “A maximum dose of 2 grams cefazolin in a solution of 1 gram/100 mL sterile saline will be injected into the affected area, followed by a 3-minute application of external...” NCT03732365 ↗ “Calcium sulfate beads will be loaded with best available antibiotics based on surgeon/infectious disease specialist determination from the following options (vancomycin,...” NCT07072923 ↗ “Some commonly used antibiotics for the treatment of PD peritonitis with their suggested concentrations in the antibiotic-lock are quoted as below: Cefazolin 10mg/mL...” NCT05971537 ↗ “'Topical Antimicrobial/Antifungal Medications' Various topical antimicrobials and antifungals include: Bacitracin; Amphotericin B; Silver Sulfadiazine; Cefazolin; Vancomycin;...” NCT00634166 ↗ “Vancomycin IV, linezolid IV or oral (outside European Union only), clindamycin IV or oral, flucloxacillin IV or oral, cefazolin IV, or cephalexin oral provided locally by the...” NCT03176134 ↗ “The investigators will administer to every patient: cefazolin 2g iv bolus, ketorolac 30 mg iv bolus, pantoprazole 40 mg iv bolus, paracetamol 1g iv perfusion (initiated 30...” NCT02502877 ↗ “Patients will be randomized at the time of surgery to receive intravenous cefazolin or clindamycin (weight-based dosing) as a pre-operative antibiotic within 60 minutes of...” NCT05367479 ↗ “Antibiotic comparator drug, IV and/or orally for 10 days. Antibiotic comparator included the following: Vancomycin, Linezolid, Clindamycin, Flucloxacillin, Cefazolin, Cephalexin.” NCT02276482 ↗ |
| Known as | Ancef | “Ancef, a 1st generation cephalosporin, was used as the primary antibiotic” NCT02579161 ↗5“Cephalosporin - Cefazolin, (Ancef, Kefzol, Cefacidil)” NCT05849090 ↗ “Ancef 1 g intravenous (IV) ( cefazolin)” NCT07032883 ↗ “Ancef or Vancomycin” NCT01458223 ↗ |
| Known as | Cefacidil | “Cephalosporin - Cefazolin, (Ancef, Kefzol, Cefacidil)” NCT05849090 ↗ |
| Known as | Cefamezin | “Cefazolin (Cefamezin)” NCT04763486 ↗ |
| Known as | Cefazolin (Ancef) | “Cefazolin (Ancef)” NCT00818766 ↗ |
| Known as | cefazolin sodium | “Patients received preoperative antibacterial prophylaxis with cefazolin sodium (or other drug if the patient was allergic to cefazolin).” PMID 23325435 ↗ May 2013 |
| Known as | Cefazolin: Brand Names Ancef | “Cefazolin: Brand Names Ancef” NCT01619982 ↗ |
| Known as | CEZ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01805856 ↗ |
| Known as | CZO | “flucloxacillin (FLU) or cefazolin (CZO)” NCT05655091 ↗ |
| Known as | Kefzol | “Cephalosporin - Cefazolin, (Ancef, Kefzol, Cefacidil)” NCT05849090 ↗ |
| Action | Inhibit | “inhibition of bacterial cell wall synthesis” NCT04775953 ↗ |
| Modality | Small molecule | “Cefazolin is a first-generation cephalosporin commonly used for perioperative surgical prophylaxis” NCT01886742 ↗ |
| Route | Intravenous | “Cefazolin IV” NCT00108433 ↗ |